DS Biopharma is a biotechnology startup that was established in 2010. The company's primary focus is to discover and develop innovative healthcare solutions with a vision to enhance the quality of life for individuals suffering from diseases for which current therapies are inadequate. Their approach involves a careful balance of applied pharmacology and clinical science to develop products that improve well-being and dignity. DS Biopharma operates in the Biotechnology, Health Care, and Pharmaceutical industries, aligning with the significant demand for advancements in healthcare. Despite their commendable mission, specific details regarding their headquarters, last investment, and the involved investors are currently unavailable.
There is no investment information
No recent news or press coverage available for DS Biopharma.
We care about your data, and we'd love to use cookies make your experience better.
